Measuring at least three cytokines, MCP-1, IFN-γ and IL-6 may be able to get very desirable information about principal responsiveness of the tumor to this treatment and, provided suppressed production of these cytokines, predict superior outcome. This evidence concerns the gene IFNG and neoplasm.